Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: PINE PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-14 to 2026-02-28
Current total value of award: $69466.32
Description: NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (6,6 DEUTERATED GLUCOSE) FOR METABOLIC RESEARCH. NONSEVERABLE